Research Highlights Varied Use of Non-Medication Strategies for Migraine Management

Recent research conducted by the University of Otago, Wellington, has shed light on the diverse approaches people with migraine disease in New Zealand use to manage their condition, emphasizing the importance of personalized treatment plans. The survey, published in the Journal of Clinical Medicine, reveals that about half of the 530 respondents employ non-pharmacological methods such as supplements and complementary therapies to alleviate their symptoms.

Participants reported using supplements like magnesium, riboflavin (vitamin B2), and coenzyme Q10. Additionally, many explored therapies including acupuncture, biofeedback, neuromodulation devices, meditation, yoga, and massage. Notably, a significant portion of the respondents—approximately 58%—currently use some form of complementary therapy.

Dr. Fiona Imlach, a senior researcher and co-founder of the Migraine Foundation, explains that while most non-medication treatments are considered safe or low risk, the evidence supporting their effectiveness can be limited. She highlights that access to certain treatments, such as neuromodulation devices, remains limited and costly in New Zealand, especially after some distributors exited the market. These devices stimulate nerves to alter pain signal processing in the brain and could potentially reduce migraine frequency and severity.

The survey also confirms that there’s no one-size-fits-all solution for migraine prevention. Many individuals try multiple approaches, with some treatments not providing relief or causing side effects, illustrating the trial-and-error nature of migraine management. Dr. Imlach underlines the urgent need for more effective options, emphasizing that New Zealand lags behind other countries in access to migraine medications and therapies.

Her research advocates for increased funding and development of both pharmacological and non-pharmacological treatments. Continued research into the underlying mechanisms of migraines and alternative therapies is essential to offer better relief for those suffering from frequent, severe attacks.

This study underscores the importance of personalized care in migraine treatment and the necessity of expanding access to a broader range of effective therapies, ultimately aiming to improve the quality of life for migraine sufferers in New Zealand.